Healthcare Innovation and Technology Lab

Directions Website

Healthcare Innovation and Technology Lab HITLAB is an impact-first organization that offers digital health research, teaching, and advisory services

Our team of anthropologists, statisticians, economists, artists, clinicians, engineers, designers, and strategists is passionate about solving healthcare’s most pressing issues. Working in New York City and New Delhi, our innovative efforts have global impact.

HITLAB is recruiting pregnant women for an IRB-approved research study evaluating a new digital maternal wellness app de...
10/08/2026

HITLAB is recruiting pregnant women for an IRB-approved research study evaluating a new digital maternal wellness app designed to support pregnancy through education, symptom tracking, health guidance, and care navigation.

👩‍⚕️ Who can participate? Pregnant women aged 18 years or older and US resident only have access to a smartphone

📱Able to provide informed consent📱

What’s involved?
Use the maternal wellness app for 30–45 days. Have brief weekly check-ins with the study team complete a few surveys/interviews to share feedback about your experience

💵 Compensation Participants who complete the study will receive USD $250 for their time and contribution to research. Your participation will help researchers better understand how digital health apps can support maternal wellbeing and improve healthcare experiences.

👉 To express interest in participation, Please fill out this form
https://lnkd.in/dMU7T_pF

📩 To learn more about the study, please contact: [email protected]🔒 Participation is voluntary.

All collected data will remain confidential.

hashtag hashtag hashtag hashtag hashtag hashtag hashtag hashtag hashtag

🤰 Are you currently pregnant? Participate in a paid study and contribute to digital health research! Fill out the form b...
09/29/2026

🤰 Are you currently pregnant? Participate in a paid study and contribute to digital health research! Fill out the form below!

HITLAB is recruiting pregnant women for an IRB-approved research studyevaluating a new digital maternal wellness app designed to support pregnancy through education, symptom tracking, health guidance, and care navigation.

👩‍⚕️ Who can participate?

▶️ Pregnant women aged 18 years or older and US resident only
▶️ Approximately 34–38 weeks pregnant (around Week 36 preferred)
▶️ Have access to a smartphone
▶️ Able to provide informed consent

📱 What’s involved?

▶️ Use the maternal wellness app for 30–45 days
▶️ Have brief weekly check-ins with the study team
▶️ Complete a few surveys/interviews to share feedback about your experience

💵 Compensation

Participants who complete the study will receive USD $250 for their time and contribution to research.

Your participation will help researchers better understand how digital health apps can support maternal wellbeing and improve healthcare experiences.

👉 To express interest in participation: https://forms.cloud.microsoft/pages/responsepage.aspx?id=dRQCxVjdw0S-NXsJxpcU8Dib7NqCOedJuOhpNGDJzr5UOEVaOEY0WjVES1ZMOUVCRlJWVkFPUEVNWiQlQCN0PWcu&route=shorturl

📩 To learn more about the study, please contact: [email protected]

🔒 Participation is voluntary. All collected data will remain confidential.

BobiHealth

HITLAB × BobiHealth: Advancing the Fight Against Preventable Maternal MortalityHITLAB and BobiHealth are launching a pro...
09/09/2026

HITLAB × BobiHealth: Advancing the Fight Against Preventable Maternal Mortality

HITLAB and BobiHealth are launching a prospective clinical pilot study to evaluate whether AI-powered pregnancy monitoring can help identify potential complications earlier, improve outcomes, and demonstrate measurable value in real-world care.

The initial 30-day pilot will evaluate clinical outcomes, economic impact, and workflow efficiency across 20 participants. Findings will help shape an expanded study of up to 100 participants over 12 months—building the real-world evidence needed to support broader adoption and a potential pilot-to-payment pathway.

At the heart of this collaboration is a critical question:
Can AI-powered monitoring help care teams recognize risk earlier—and ultimately prevent complications that too often become life-threatening?

HITLAB will lead the study’s research and evaluation, including regulatory management, participant recruitment, data collection and analysis, and dissemination of findings to the maternal health and payer communities.

This partnership represents an important step toward moving promising maternal health technology from innovation to clinically validated, evidence-based care.

🔗 Read the full announcement and learn more about the study: https://www.hitlab.org/bobi-health-launch-clinical-study-2026/

🤰Are you currently pregnant? Participate in a paid study and contribute to digital health research! Fill out the applica...
09/03/2026

🤰Are you currently pregnant? Participate in a paid study and contribute to digital health research! Fill out the application form now | Link Below!

HITLAB is recruiting pregnant women for an IRB-approved research study evaluating a new digital maternal wellness app designed to support pregnancy through education, symptom tracking, health guidance, and care navigation.

👩‍⚕️ Who can participate?
👉 Pregnant women aged 18 years or older and US resident only
👉 Approximately 34–38 weeks pregnant (around Week 36 preferred)
👉 Have access to a smartphone 📱
👉 Able to provide informed consent

📱 What’s involved?
👉 Use the maternal wellness app for 30–45 days
👉 Have brief weekly check-ins with the study team
👉 Complete a few surveys/interviews to share feedback about your experience

💵 Compensation
Participants who complete the study will receive USD $250 for their time and contribution to research.

Your participation will help researchers better understand how digital health apps can support maternal wellbeing and improve healthcare experiences.

Your participation will help researchers better understand how digital health apps can support maternal wellbeing and improve healthcare experiences.

👉 To express interest in participation,: Please fill out this form: https://forms.cloud.microsoft/pages/responsepage.aspx?id=dRQCxVjdw0S-NXsJxpcU8Dib7NqCOedJuOhpNGDJzr5UOEVaOEY0WjVES1ZMOUVCRlJWVkFPUEVNWiQlQCN0PWcu&route=shorturl

📩 To learn more about the study, please contact:
[email protected]

🔒 Participation is voluntary. All collected data will remain confidential.

Big News | HITLAB & MyCareGorithm Partner to Bring Evidence-Based Innovation to Oncology | Read on!What if the cancer co...
08/13/2026

Big News | HITLAB & MyCareGorithm Partner to Bring Evidence-Based Innovation to Oncology | Read on!

What if the cancer consultation could become the beginning of understanding—not confusion?

For many cancer patients, diagnosis and treatment conversations are overwhelming, making it difficult to remember, process, and act on critical information after leaving the exam room.

HITLAB is partnering with MyCareGorithm to independently evaluate a digital consultation platform designed to make complex oncology conversations more visual, understandable, and actionable.

👉 The study will examine:

☑️ Patient understanding, engagement, and confidence
☑️ Shared decision-making and decision conflict
☑️ Consultation efficiency and provider workflow
☑️ The clinical, operational, and economic evidence needed for real-world adoption

This partnership reflects HITLAB's commitment to independent, rigorous evaluation of healthcare innovation—helping health systems identify technologies that can deliver measurable value for both patients and care teams.

📖 Read the full HITLAB announcement and learn how this research could help redefine patient-centered cancer communication.

👉 Read the announcement:
https://www.hitlab.org/cancer-mycaregorithm-2026/

What would make a cancer consultation more understandable for patients and families? Share your perspective below.👇

🎉 Congratulations to Our Partner Alphyn Biologic, Inc. on a Significant Clinical Milestone!HITLAB is pleased to congratu...
08/03/2026

🎉 Congratulations to Our Partner Alphyn Biologic, Inc. on a Significant Clinical Milestone!

HITLAB is pleased to congratulate our partner on reaching an important achievement in the development of potential new treatments for molluscum contagiosum (MC).

The successful completion of treatment for the last patient enrolled in the Phase 2 clinical trial of Zabalafin Hydrogelmarks a major milestone in the clinical development process.

There remains a significant need for treatment options that are effective, safe, well tolerated, and painless for individuals living with molluscum contagiosum. We look forward to the upcoming study results and the continued advancement of innovative therapies that have the potential to improve patient care.

This milestone also represents continued progress for the Zabalafin Platform, reflecting ongoing efforts to bring new therapeutic innovations to patients.

👉 Learn more about Alphyn: https://alphynbiologics.com

Congratulations to the entire team on this achievement. We look forward to following the next phase of this exciting journey.

Early Bird Registration for HITLAB Fall Summit 2026 is NOW OPEN!What if one conversation this December led to your next ...
07/06/2026

Early Bird Registration for HITLAB Fall Summit 2026 is NOW OPEN!

What if one conversation this December led to your next partnership, investment, research collaboration, or breakthrough innovation?

Join healthcare leaders and innovators December 1–3, 2026 at the Microsoft Technology Center, New York City, for three days of thought-provoking discussions, networking, and evidence-based innovation.

Hear from leaders representing Merck, Bayer, Northwell Health, Aetna, a CVS Health Company, Blue Shield of California, Medidata Solutions, and many more across healthcare, AI, digital health, life sciences, MedTech, and health innovation.

🎟️ Secure your Early Bird Pass today before prices increase.

👉 Get your Summit Pass:
https://www.hitlab.org/product/fall-2026-summit-general-3-day-pass/

Be part of the conversations shaping the future of healthcare.

📍 Microsoft Technology Center, New York City
🗓️ December 1–3, 2026

Tag a colleague who should join you! 👇

🔄 DAY 1 REWIND: INNOVATION TOOK CENTER STAGE! LETS LOOK BACK!As teams continue building, coding, and collaborating durin...
06/18/2026

🔄 DAY 1 REWIND: INNOVATION TOOK CENTER STAGE! LETS LOOK BACK!

As teams continue building, coding, and collaborating during Day 2 of the HITLAB x UVU Innovation Hackathon, we're taking a moment to look back at an unforgettable Pitch Day.

From more than 1,200 global applicants, 10 extraordinary finalists took the stage at Utah Valley University to showcase bold ideas shaping the future of healthcare, AI, and emerging technology.

🏆 Congratulations again to our winners:
🥇 BobiHealth
🥈 BioTrillion
🥉 CERN Corporation

"Bobi Health, BioTrillion, and Cern Corporation (Cern Device) each showed us what's possible when bold thinking meets real ex*****on. These teams aren't just building products—they're building the next chapter of healthcare innovation, and HITLAB is proud to help accelerate that work."
— Dr. Stan Kachnowski, Chair, HITLAB

"Watching our finalists pitch today was a reminder of why we built this program. Bobi Health and our runner-ups represent the kind of applied, real-world thinking that UVU students and partners are bringing to AI and healthcare every day."
— Barclay Burns, Chief AI Officer, UVU

And while only three teams could take home awards, every finalist raised the bar.
"All the candidates were amazing. We wish we could have recognized every one of them—we're grateful to each team for the work and passion they brought to the stage."
— Dr. Stan Kachnowski, Chair, HITLAB

🚀 The pitches may be over, but the innovation continues.
Now it's time for our hackers, builders, founders, and innovators to create what's next.

Stay tuned for Day 2 updates!

We Have Officially Started! We Have An Official Winner of Dell Laptop Powered With Nvidia Chip! Stay Tuned For More Upda...
06/17/2026

We Have Officially Started! We Have An Official Winner of Dell Laptop Powered With Nvidia Chip! Stay Tuned For More Updates & Our Pitchday Winner!

The HITLAB World Cup Innovation Pitch Day 2026 is now underway at Utah Valley University.

Today, our Top 10 Finalists take the stage to present breakthrough innovations that could shape the future of healthcare, artificial intelligence, digital health, life sciences, and emerging technologies.

And We Have Official Winner of Dell Laptop Powered With Nvidia Chip handed by Juan Alfaro from Dell Technologies to David Balkcom!!

From visionary founders and startup leaders to researchers and innovators, these finalists have emerged from a highly competitive global pool and are now pitching their solutions to an audience of investors, industry leaders, healthcare executives, technology pioneers, and innovation champions.

06/17/2026

2 Hours To Kickoff! The countdown is almost over. HITLAB x UVU World Cup Innovation Pitchday Finals & Hackathon!

In just 2 hours, the world's next generation of innovators, founders, researchers, and entrepreneurs will take the stage at the HITLAB World Cup Innovation Pitch Day & Hackathon 2026 at Utah Valley University.

After a highly competitive selection process, our Top 10 Finalists will present their groundbreaking innovations to an audience of investors, industry leaders, healthcare executives, technology pioneers, and innovation champions.

🏆 Meet the Pitchday Finalists:

▶️ Glya
▶️ Nightingale Health
▶️ Memorylane TV
▶️ TriAxis Biosciences
▶️ Altin Biosciences
▶️ BioTrillion
▶️ CERN Corporation Inc.(Cern Device)
▶️ BobiHealth
▶️ Panacea
▶️ healthKERI (Techstars '25)

Joining us are leaders, executives, founders, investors, and innovators from organizations including Microsoft, Google, Dell, Deloitte, Goldman Sachs, Amazon.com, Tesla, McKesson, Optum, Motorola Solutions, Adobe, stryker & Many more!

Big ideas. Bold founders. Breakthrough innovation.

👉 Today, 10 finalists pitch.
👉 Tomorrow, they could transform industries!
👉 Follow along as we celebrate the innovators building the future.

Who will take home the title? Stay tuned!

Address

3960 Broadway
New York, NY
10032

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 6pm
Thursday 9am - 6pm
Friday 9am - 6pm

Website

Alerts

Be the first to know and let us send you an email when Healthcare Innovation and Technology Lab posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category